News

November 7, 2007 - Patients’ own stem cells injected into their hearts after treatment for an ST elevation heart attack improved their hearts’ improved pumping ability, researchers reported during...

September 13, 2007 - Millennium Research Group (MRG) conducted a detailed analysis of the stem cell therapy market in its "U.S. Markets for Stem Cell Therapies 2007" report, which shows while the...

September 11, 2007 - CellCyte Genetics Corp. has entered into a collaborative research agreement with physician scientists at the Cleveland Clinic Foundation to investigate the presence and...

August 28, 2007 - Human embryonic stem cell (hESC)-derived cardiomyocytes improve heart function when transplanted after myocardial infarction, according to a study published in Nature...

June 11, 2007 — Cardio BioSciences and Mayo Clinic announced today that they have entered into a collaborative agreement related to the licensing of Mayo Clinic research, know-how and intellectual...

May 7, 2007 — Australia's adult stem cell company, Mesoblast Limited, has announced that the FDA has cleared the Investigational New Drug Submission (IND) of its U.S.-based sister company,...

Dr. Nabil Dib, M.D., M.Sc., director of Cardiovascular Cell Therapy at University of California San Diego, reported how 23 patients in an FDA trial were safely transformed from advanced heart...

March 29, 2007 — At the ACC this week Dr. Nabil Dib, M.D., M.Sc., director of Cardiovascular Cell Therapy at University of California San Diego, reported how 23 patients in an FDA trial were...

Feb. 7, 2007 — A first ever human procedure in Madrid took place this week in which a heart failure patient received adult stem cells removed from his own adipose (fat) tissue by liposuction. The...

The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The New York Academy of Medicine in New York, NY. The three-day program is dedicated to...

In its third quarter financial report, San Diego-based Cytori said it has moved significantly closer to initiating its cardiovascular clinical trials," said Christopher J. Calhoun, chief executive...